ESSA Pharma competitorsClear all

ESSA Pharma's top competitors include MEI Pharma, Candel Therapeutics, Urogen Pharma, AZTherapies and Catabasis Pharmaceuticals.
ESSA Pharma
ESSA Pharma
ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
MEI Pharma
MEI Pharma
MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.
Candel Therapeutics
Candel Therapeutics
Candel Therapeutics (also known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
Urogen Pharma
Urogen Pharma
UroGen Pharma is a clinical-stage biopharmaceutical company.
AZTherapies
AZTherapies
AZTherapies is a developer of pharmaceutical drugs designed to provide treatment for multiple neurodegenerations and neuroinflammation-related CNS diseases.
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals discovers and develops innovative drugs for treating inflammatory conditions.
Founding Date
Founding Date
2009
Founding Date
2000
Founding Date
N/A
Founding Date
2004
Founding Date
2011
Founding Date
2008
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Vancouver, CA HQ
Houston, US
South San Francisco, US
Locations
San Diego, US HQ
San Diego, US
Locations
Arlington, US HQ
Needham, US
Locations
New York, US HQ
Tel Aviv Yafo, IL
Princeton, US
Locations
Boston, US HQ
Locations
Boston, US HQ
Employees
Employees
25
Employees
4025% increase
Employees
44
Employees
4245% increase
Employees
323% decrease
Employees
2433% decrease
Valuation ($)
Valuation ($)
1.1 b
Valuation ($)
370.2 m
Valuation ($)
N/A
Valuation ($)
384 m
Valuation ($)
N/A
Valuation ($)
48.5 m
Twitter followers
Twitter followers
72
Twitter followers
N/A
Twitter followers
80
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
861
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
3
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.7
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3.7
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
83.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
241909
Alexa Website Rank
499514
Alexa Website Rank
399428
Alexa Website Rank
218835
Alexa Website Rank
179800
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
2.6
Employee Rating
5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$28.9m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$11.8m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$2.7m (FY, 2020)
Cost of goods
N/A
Cost of goods
$1m (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$26.2m (FY, 2020)
Gross profit
N/A
Gross profit
$10.8m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($23.4m) (FY, 2020)
Net income
($46m) (FY, 2020)
Net income
N/A
Net income
($128.5m) (FY, 2020)
Net income
N/A
Net income
($37.3m) (FY, 2020)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 22.5m (about 2 years ago)
Latest funding round
N/A
Latest funding round
$ 33.6m (9 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 74.1m
Total funding raised
$ 1.1m
Total funding raised
$ 51.2m
Total funding raised
N/A
Total funding raised
$ 97.7m
Total funding raised
$ 94.9m
For sources of this data, please see the company profile

View company profiles

MEI Pharma
HQ
San Diego, US
Employees
40↑ 25% increase

MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.

View company
Candel Therapeutics
HQ
Arlington, US
Employees
44

Candel Therapeutics (also known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.

View company
Urogen Pharma
HQ
New York, US
Employees
42↑ 45% increase

UroGen Pharma is a clinical-stage biopharmaceutical company.

View company
AZTherapies
HQ
Boston, US
Employees
32↓ 3% decrease

AZTherapies is a developer of pharmaceutical drugs designed to provide treatment for multiple neurodegenerations and neuroinflammation-related CNS diseases.

View company